Download PDF
Neuropediatrics 2001; 32(1): 28-37
DOI: 10.1055/s-2001-12219
Original Article

Georg Thieme Verlag Stuttgart · New York

Long-Term MRI Observations of Childhood-Onset Relapsing-Remitting Multiple Sclerosis

Cs. Balássy1,2 , G. Bernert3 , C. Wöber-Bingöl3 , B. Csapó4 , B. Kornek5 , J. Széles4 , D. Fleischmann1 , D. Prayer1,2
  • 1 Department of Radiology, University of Vienna, Vienna, Austria
  • 2 Division of Neuroradiology, University of Vienna, Vienna, Austria
  • 3 Department of Pediatrics, University of Vienna, Vienna, Austria
  • 4 Department of Surgery, University of Vienna, Vienna, Austria
  • 5 Brain Research Institute, Division of Neuroimmunology, University of Vienna, Vienna, Austria
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints

Purpose: Long-term MRI follow-up of childhood-onset relapsing-remitting multiple sclerosis (RRMS) was carried out in 4 cases. MRI findings were correlated with clinical course and characteristic differences from adult-onset RRMS were elaborated. Methods: Two girls and one boy with true childhood-onset, and one girl with juvenile-onset RRMS underwent 5 - 16 MRI examinations within 6 - 8 years. The total number of lesions, the numbers of new, active, disappearing and reappearing lesions, infratentorial and U-fibre lesions, “giant” plaques and “black holes” were counted. Callosal atrophy and general brain atrophy were assessed. The findings were related to the physical status according to the Expanded Disability Status Scale (EDSS). Results and Conclusions: Results showed that the primary differences in childhood-onset RRMS compared to adult-onset RRMS lie in the lack of, or slower development of irreversible changes (“black hole” formation, brain atrophy). Despite callosal atrophy and intensive U-fibre region involvement, school performance was unchanged. Regarding the frequency of “giant” lesions, an even more pronounced white matter involvement was found in our children compared to adults. All children exhibited a rather “benign” disease course. A more intensive remyelination, less severe neuronal loss, and higher functional brain plasticity at younger ages may account for these differences.

Key words

Multiple sclerosis - MRI - Childhood-onset - Long-term follow-up

References

  • 1 Bauer H J, Hanefeld F, Christen H J. Multiple sclerosis in early childhood.  Lancet. 1990;  336 1190
    PubMedGoogle Scholar
  • 2 Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology.  Ann Neurol. 1997;  42 783-793
    CrossrefPubMedGoogle Scholar
  • 3 Cole G F, Stuart C A. A long perspective on childhood multiple sclerosis.  Dev Med Child Neurol. 1995;  37 661-666
    PubMedGoogle Scholar
  • 4 Demiel L T, Copelman C A, Cuzner M L. Macrophages in CNS remyelination: friend or foe?.  Neurochem Res. 1998;  23 341-347
    CrossrefPubMedGoogle Scholar
  • 5 Duquette P, Murray T J, Pleines J, Ebers G C, Sadovnick D, Weldon P. et al . Multiple sclerosis in childhood: clinical profile in 125 patients.  J Pediatr. 1987;  111 359-363
    CrossrefPubMedGoogle Scholar
  • 6 Ebner F, Millner M M, Justich E. Multiple sclerosis in children: value of serial MR studies to monitor patients.  AJNR Am J Neuroradiol. 1990;  11 1023-1027
    PubMedGoogle Scholar
  • 7 Filippi M, Horsfield M A, Tofts P S, Barkhof F, Thompson A J, Miller D H. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis.  Brain. 1995;  118 1601-1612
    PubMedGoogle Scholar
  • 8 Gall J C, Hayles A B, Siekert R G, Keith H M. Multiple sclerosis in children.  Pediatrics. 1958;  21 703-711
    PubMedGoogle Scholar
  • 9 Gallucci M, Caulo M, Masciocchi C. Acquired inflammatory white matter diseases (abstract).  Child's Nervous System. 2000;  16 66-67
    PubMedGoogle Scholar
  • 10 Gass A, Filippi M, Rodegher M E, Schwartz A, Comi G, Hennerici M G. Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI.  Neurology. 1998;  50 548-550
    PubMedGoogle Scholar
  • 11 Gean-Marton A D, Vezina L G, Marton K I, Stimac G K, Peyster R G, Taveras J M. et al . Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis.  Radiology. 1991;  180 215-221
    PubMedGoogle Scholar
  • 12 Gebarski S S, Gabrielsen T O, Gilman S, Knake J E, Latack J T, Aisen A M. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging.  Ann Neurol. 1985;  17 469-474
    CrossrefPubMedGoogle Scholar
  • 13 Ghezzi A, Deplano V, Faroni J, Grasso M G, Liguori M, Marrosu G. et al . Multiple sclerosis in childhood: clinical features of 149 cases.  Mult Scler. 1997;  3 43-46
    CrossrefPubMedGoogle Scholar
  • 14 Golden G S, Woody R C. The role of nuclear magnetic resonance imaging in the diagnosis of MS in childhood.  Neurology. 1987;  37 689-693
    PubMedGoogle Scholar
  • 15 Guilhoto L M, Osorio C A, Machado L R, de Castro C P, Manreza M L, Callegaro D. et al . Pediatric multiple sclerosis report of 14 cases.  Brain Dev. 1995;  17 9-12
    PubMedGoogle Scholar
  • 16 Haas G, Schroth G, Krägeloh-Mann I, Buchwald-Saal M. Magnetic resonance imaging of the brain of children with multiple sclerosis.  Dev Med Child Neurol. 1987;  29 586-591
    PubMedGoogle Scholar
  • 17 Hanefeld F. Multiple sclerosis in childhood.  Curr Opin Neurol Neurosurg. 1992;  5 359-363
    PubMedGoogle Scholar
  • 18 Hanefeld F, Bauer H J, Christen H J, Kruse B, Bruhn H, Frahm J. Multiple sclerosis in childhood: report of 15 cases.  Brain Dev. 1991;  13 410-416
    PubMedGoogle Scholar
  • 19 Huber S J, Paulson G W, Shuttleworth E C, Chakeres D, Clapp L E, Pakalnis A. et al . Magnetic resonance imaging correlates of dementia in multiple sclerosis.  Arch Neurol. 1987;  44 732-736
    PubMedGoogle Scholar
  • 20 Knaap M Svd, Valk J. Multiple slerosis. Knaap MSvd, Valk J Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 2nd ed. Berlin, New York; Springer 1995: 296-313
    Google Scholar
  • 21 Kurtzke J F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).  Neurology. 1983;  33 1444-1452
    CrossrefPubMedGoogle Scholar
  • 22 Lassmann H. The pathology in multiple sclerosis. Compston A McAlpine's Multiple Sclerosis. 3rd ed. London; Churchill Livingstone 1998: 323-358
    Google Scholar
  • 23 Losseff N A, Wang L, Lai H M, Yoo D S, Gawne-Cain M L, McDonald W I. et al . Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.  Brain. 1996;  119 2009-2019
    CrossrefPubMedGoogle Scholar
  • 24 Matthews B. Symptoms and signs of multiple sclerosis. Compston A McAlpine's Multiple Sclerosis. 3rd ed. London; Churchill Livingstone 1998: 186-190
    Google Scholar
  • 25 Miki Y, Grossman R I, Udupa J K, Wei L, Kolson D L, Mannon L J. et al . Isolated U-fiber involvement in MS: preliminary observations.  Neurology. 1998;  50 1301-1306
    PubMedGoogle Scholar
  • 26 Miki Y, Grossman R I, Udupa J K, Wei L, Polansky M, Mannon L J. et al . Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images - lack of correlation between changes in T2 lesion volume and clinical findings.  Radiology. 1999;  213 395-399
    PubMedGoogle Scholar
  • 27 Miller D H. Spektrum der Veränderungen bei Multipler Sklerose. Miller DH, Kesselring J, McDonald WI, Paty DW, Thompson AJ Magnetresonanz bei Multipler Sklerose. Stuttgart; Kohlhammer 1998: 37
    Google Scholar
  • 28 Millner M M, Ebner F, Justich E, Urban C. Multiple sclerosis in childhood: contribution of serial MRI to earlier diagnosis.  Dev Med Child Neurol. 1990;  32 769-777
    PubMedGoogle Scholar
  • 29 Nieuwenhuys R, Voogd J, Huijzen van C. Long association and commissural connections. Nieuwenhuys R, Voogd J, Huijzen C van The Human Central Nervous System: A Synopsis and Atlas. 3rd rev. ed. Berlin, New York; Springer 1988: 365-375
    Google Scholar
  • 30 Nowell M A, Grossman R I, Hackney D B, Zimmerman R A, Goldberg H I, Bilaniuk L T. MR imaging of white matter disease in children.  AJR Am J Roentgenol. 1988;  151 359-365
    PubMedGoogle Scholar
  • 31 Paty D W, Oger J J, Kastrukoff L F, Hashimoto S A, Hooge J P, Eisen A A. et al . MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.  Neurology. 1988;  38 180-185
    CrossrefPubMedGoogle Scholar
  • 32 Pinhas-Hamiel O, Barak Y, Siev-Ner I, Achiron A. Juvenile multiple sclerosis: clinical features and prognostic characteristics.  J Pediatr. 1998;  132 735-737
    PubMedGoogle Scholar
  • 33 Poser C M, Paty D W, Scheinberg L, McDonald W I, Davis F A, Ebers G C. et al . New diagnostic criteria for multiple sclerosis: guidelines for research protocols.  Ann Neurol. 1983;  13 227-231
    CrossrefPubMedGoogle Scholar
  • 34 Poser S, Raun N E, Poser W. Age at onset, initial symptomatology and the course of multiple sclerosis.  Acta Neurol Scand. 1982;  66 355-362
    PubMedGoogle Scholar
  • 35 Prineas J W, Barbard R O, Revesz T, Kwon E E, Sharer L, Cho E S. Multiple sclerosis. Pathology recurrent lesions.  Brain. 1993;  116 681-693
    PubMedGoogle Scholar
  • 36 Rovaris M, Filippi M, Minicucci L, Iannucci G, Santuccio G, Possa F. et al . Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis.  AJNR Am J Neuroradiol. 2000;  21 402-408
    PubMedGoogle Scholar
  • 37 Ruggieri M, Polizzi A, Pavone L, Grimaldi L M. Multiple sclerosis in children under 6 years of age.  Neurology. 1999;  53 478-484
    PubMedGoogle Scholar
  • 38 Scaioli V, Rumi V, Cimino C, Angelini L. Childhood multiple sclerosis (MS): multimodal evoked potentials (EP) and magnetic resonance imaging (MRI) comparative study.  Neuropediatrics. 1991;  22 15-23
    PubMedGoogle Scholar
  • 39 Shaw C M, Alvord E C. Multiple sclerosis beginning in infancy.  J Child Neurol. 1987;  2 252-256
    PubMedGoogle Scholar
  • 40 Silber E, Sharief M K. Axonal degeneration in the pathogenesis of multiple sclerosis.  J Neurol Sci. 1999;  170 11-18
    CrossrefPubMedGoogle Scholar
  • 41 Simon J H, Jacobs L D, Campion M K, Rudick R A, Cookfair D L, Herndon R M. et al . A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).  Neurology. 1999;  53 139-148
    CrossrefPubMedGoogle Scholar
  • 42 Smith M E, Eller N L, McFarland H F, Racke M K, Raine C S. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.  Am J Pathol. 1999;  155 1147-1161
    PubMedGoogle Scholar
  • 43 Smith M E, Stone L A, Albert P S, Frank J A, Martin R, Armstrong M. et al . Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.  Ann Neurol. 1993;  33 480-489
    CrossrefPubMedGoogle Scholar
  • 44 Steingart A, Hachinski V C, Lau C, Fox A J, Diaz F, Cape R. et al . Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis).  Arch Neurol. 1987;  44 32-35
    PubMedGoogle Scholar
  • 45 Thompson A J, Miller D, Youl B, MacManus D, Moore S, Kingsley D. et al . Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.  Neurology. 1992;  42 60-63
    PubMedGoogle Scholar
  • 46 Trapp B D, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability.  Curr Opin Neurol. 1999;  12 295-302
    CrossrefPubMedGoogle Scholar
  • 47 Truyen L, van Waesberghe J H, van Walderveen M A, van Oosten B W, Polman C H, Hommes O R. et al . Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.  Neurology. 1996;  47 1469-1476
    PubMedGoogle Scholar
  • 48 Uhlenbrock D, Sehlen S. The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE).  Neuroradiology. 1989;  31 203-212
    CrossrefPubMedGoogle Scholar
  • 49 van Waesberghe J H, Kamphorst W, De Groot C J, van Walderveen M A, Castelijns J A, Ravid R. et al . Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.  Ann Neurol. 1999;  46 747-754
    CrossrefPubMedGoogle Scholar
  • 50 van Waesberghe J H, van Walderveen M A, Castelijns J A, Scheltens P, Lycklama a Nijeholt G J, Polman C H. et al . Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR.  AJNR Am J Neuroradiol. 1998;  19 675-683
    PubMedGoogle Scholar
  • 51 van Walderveen M A, Barkhof F, Hommes O R, Polman C H, Tobi H, Frequin S T. et al . Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.  Neurology. 1995;  45 1684-1690
    PubMedGoogle Scholar
  • 52 van Walderveen M A, Kamphorst W, Scheltens P, van Waesberghe J H, Ravid R, Valk J. et al . Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis.  Neurology. 1998;  50 1282-1288
    PubMedGoogle Scholar
  • 53 Weinshenker B G, Bass B, Rice G P, Noseworthy J, Carriere W, Baskerville J. et al . The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.  Brain. 1989;  112 1419-1428
    CrossrefPubMedGoogle Scholar
  • 54 Youl B D, Kermode A G, Thompson A J, Revesz T, Scaravilli F, Barnard R O. et al . Destructive lesions in demyelinating disease.  J Neurol Neurosurg Psychiatry. 1991;  54 288-292
    PubMedGoogle Scholar

Dr. Csilla Balássy

Department of Radiology
University of Vienna

Währinger Gürtel 18 - 20

1090 Vienna

Austria

Email: csilla.balassy@rad.akh.magwien.gv.at

      >